FDA Approves Phases II and IIa Clinical Trial of L-Serine    See links to FDA-approved Phase II clinical trial of L-serine for ALS patients and  Phase IIa  clinical trial of L-serine for early stage Alzheimer's patients 

FDA Approves Phases II and IIa Clinical Trial of L-Serine

See links to FDA-approved Phase II clinical trial of L-serine for ALS patients and Phase IIa clinical trial of L-serine for early stage Alzheimer's patients 

L-serine.png

L-Serine Safe for ALS Patients. 

We completed a Phase I ALS trial (to demonstrate the safety of the naturally occurring amino acid, L-serine, in humans) that showed encouraging signs of slowing disease progression among enrolled patients.

Ogimi

L-Serine's Potential for ALS Patients. 

Ogimi Village is Renowned for its Aging Population. We sought to determine if the L-serine content of their diet could account for their neurological health.

L-serine